Viridian Therapeutics, Inc.\DE insider trading activity
Understanding Insider Activity at Viridian Therapeutics, Inc.\DE
Welcome to our dedicated page for Viridian Therapeutics, Inc.\DE (Nasdaq: VRDN) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Viridian Therapeutics, Inc.\DE's key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for Viridian Therapeutics, Inc.\DE, and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for VRDN| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| VRDN | 11:12:50 PM, 09/30/2024 | Beetham Thomas W.(Chief Operating Officer) purchased 5000 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$117050 | Filing |
| VRDN | 11:10:58 PM, 09/30/2024 | Mahoney Stephen F.(President and CEO) purchased 21400 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$499261 | Filing |
| VRDN | 01:00:13 AM, 09/18/2024 | Fairmount Funds Management LLC purchased 1600000 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$30000000 | Filing |
| VRDN | 11:44:41 PM, 01/24/2024 | Fairmount Funds Management LLC purchased 476190 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$9999990 | Filing |
| VRDN | 09:23:01 PM, 06/20/2023 | Meisner Lara(Chief Legal Officer) sold 2296 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$64342 | Filing |
| VRDN | 11:41:29 PM, 06/06/2023 | Meisner Lara(Chief Legal Officer) sold 7500 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$186134 | Filing |
| VRDN | 11:05:46 PM, 04/12/2023 | Myers Scott Dunseth(Chief Executive Officer) purchased 4000 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$101480 | Filing |
| VRDN | 08:06:51 PM, 03/13/2023 | Myers Scott Dunseth(Chief Executive Officer) purchased 5500 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$160325 | Filing |
| VRDN | 09:05:12 PM, 03/10/2023 | Meisner Lara(General Counsel and Secretary) sold 29971 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$871256 | Filing |
| VRDN | 11:35:01 PM, 02/07/2023 | Violin Jonathan(Chief Executive Officer) sold 50000 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$1839999 | Filing |
| VRDN | 11:12:08 PM, 02/03/2023 | Violin Jonathan(Chief Executive Officer) sold 50000 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$1839999 | Filing |
| VRDN | 11:04:31 PM, 01/25/2023 | Meisner Lara(General Counsel and Secretary) sold 6843 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$244021 | Filing |
| VRDN | 10:58:22 PM, 01/18/2023 | Katz Barrett(Chief Medical Officer) sold 29000 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$1078260 | Filing |
| VRDN | 12:09:33 AM, 01/12/2023 | Katz Barrett(Chief Medical Officer) sold 60000 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$2089471 | Filing |
| VRDN | 09:42:42 PM, 12/22/2022 | Meisner Lara(General Counsel and Secretary) sold 16926 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$493397 | Filing |
| VRDN | 12:22:53 AM, 12/20/2022 | Meisner Lara(General Counsel and Secretary) sold 1597 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$45310 | Filing |
| VRDN | 01:56:50 AM, 12/15/2022 | Meisner Lara(General Counsel and Secretary) sold 16256 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$457076 | Filing |
| VRDN | 11:45:46 PM, 11/16/2022 | Meisner Lara(General Counsel and Secretary) sold 8125 shares of Viridian Therapeutics, Inc.\DE (VRDN) for ~$179156 | Filing |
Discover the Complete Picture 🔒
Currently viewing just 6 of 18 insider filings.
Register now to dive deeper and explore the full dataset.